Clincosm LogoSign in Get a demo

Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block

Sponsor
Samsun University (Other)
Overall Status
Completed
CT.gov ID
NCT06054945
Collaborator
(none)
88
Enrollment
1
Location
12
Actual Duration (Days)
223.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In our clinic, routine suprainguinal fascia iliaca block (SIFIB) has been administered for postoperative analgesia in patients undergoing knee arthroplasty. Recently, we have introduced the IPACK (Infiltration between the Popliteal Artery and Capsule of the Knee) block to this regimen, and the aim of this retrospective study is to determine whether the addition of the IPACK block enhances the quality of analgesia.

Knee arthroplasty, also known as knee joint replacement surgery, is a common procedure performed to alleviate pain and improve joint function in patients with knee osteoarthritis or other knee-related conditions. Postoperative pain management is crucial for patient comfort and overall recovery.

In this study, we aimed to compare the two techniques mentioned earlier, namely the SIFIB (Suprainguinal Fascia Iliaca Block) and the SIFIB+IPACK, by examining the data of patients who underwent knee arthroplasty under spinal anesthesia at our clinic between January 1, 2023, and September 1, 2023.

Condition or Disease Intervention/Treatment Phase
  • Procedure: SIFIB (suprainguinal fascia iliaca block)
  • Other: IPACK (Interspace between the popliteal artery and capsule of the posterior knee )
  • Device: Patient controlled anagesia device

Study Design

Study Type:
Observational
Actual Enrollment :
88 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block in Knee Arthroplasty Patients Under Spinal Anesthesia: A Retrospective Cohort Study
Actual Study Start Date :
Sep 3, 2023
Actual Primary Completion Date :
Sep 15, 2023
Actual Study Completion Date :
Sep 15, 2023

Arms and Interventions

Arm Intervention/Treatment
SIFIB

Patients who underwent SIFIB in knee arthroplasty patients under spinal anesthesia will be evaluated retrospectively in terms of opioid consumption and NRS scores.

Procedure: SIFIB (suprainguinal fascia iliaca block)
Ultrasound guided Suprainguinal Fascia Iliaca Block for Knee Arthroplasty Patients

Device: Patient controlled anagesia device
Those who were administered opioids with PCA as rescue analgesic in the postoperative analgesia plan on the selected dates will be included in the study.
Other Names:
  • PCA

    		•
    SIFIB+IPACK

    Patients who underwent SIFIB+IPACK blocks in knee arthroplasty patients under spinal anesthesia will be evaluated retrospectively in terms of opioid consumption and NRS scores.

    Procedure: SIFIB (suprainguinal fascia iliaca block)
    Ultrasound guided Suprainguinal Fascia Iliaca Block for Knee Arthroplasty Patients

    Other: IPACK (Interspace between the popliteal artery and capsule of the posterior knee )
    Ultrasound guided IPACK (Interspace between the popliteal artery and capsule of the posterior knee ) Block for Knee Arthroplasty Patients

    Device: Patient controlled anagesia device
    Those who were administered opioids with PCA as rescue analgesic in the postoperative analgesia plan on the selected dates will be included in the study.
    Other Names:
  • PCA

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Opioid consumption [24 hours]

      Opioid consumption via PCA device

    Secondary Outcome Measures

    1. NRS scores [24 hours]

      NRS scores in different time frames. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10, that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Patients meeting the following criteria and whose postoperative follow-up forms were completed in full were included in the study

    • Patients underwent total knee arthroplasty (TKA)

    • ASA class I to III.

    • operated under spinal anesthesia

    • patient controlled analjgesia device was used for analgesia

    Exclusion Criteria:

    Patients whose data were inaccessible or had incomplete follow-up forms were excluded from the study to ensure the accuracy and reliability of our analysis.

    • PCA device problems in follow up in 24 hours

    • anesthesia plans were converted to general anesthesia

    • spinal anesthesia failure

    • peripheral blocks used other than protocol

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Samsun University Samsun Turkey

    Sponsors and Collaborators

    • Samsun University

    Investigators

    • Principal Investigator: Hatice Kusderci, M.D., Samsun University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Samsun University
    ClinicalTrials.gov Identifier:
    NCT06054945
    Other Study ID Numbers:
    • SIFIB+IPACK
    First Posted:
    Sep 26, 2023
    Last Update Posted:
    Sep 29, 2023
    Last Verified:
    Sep 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Samsun University
    analgesia
    IPACK
    SIFIB
    Additional relevant MeSH terms:
    Acute Pain

    Study Results

    No Results Posted as of Sep 29, 2023